Loading Events

« All Events

  • This event has passed.

Cases and Considerations in PAH: From Diagnosis to Effective Treatment

October 17, 2021 from 5:15 pm - 6:15 pm CDT

Supported By: Actelion, a Janssen pharmaceutical company of Johnson & Johnson, Bayer, Merck, and United Therapeutics

VISIT EVENT NOW

Program Description

In this interactive CME live symposium, experts in the field of pulmonary arterial hypertension (PAH) will engage in discussion and dissect a patient case that addresses best practices for recognizing, diagnosing, and treating PAH in clinical practice to improve patient outcomes. By participating in this activity, learners will gain insight to evidence-based approaches to appropriate risk assessment in PAH, guideline-directed strategies to set and treat to specific PAH treatment goals, best practices to tailor and adjust PAH therapy to meet treatment goals and achieve low-risk status, as well as approaches to effectively monitor PAH patients throughout the course of the disease.

Disclaimer: This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians

Speakers

Vallerie V. McLaughlin, MD, FACC, FAHA, FCCP
Kim A. Eagle, MD, Endowed Professor of Cardiovascular Medicine
Director,
Pulmonary Hypertension Program
University of Michigan
Ann Arbor, Michigan

Murali Chakinala, MD, FCCP
Professor of Medicine,
Washington University
Director,
Washington University &
Barnes-Jewish Hospital Pulmonary Hypertension Care Center
St Louis, Missouri

Resources

Registration: www.medscape.org/symposium/pulmonary-hypertension

Details

Date:
October 17, 2021
Time:
5:15 pm - 6:15 pm CDT
Event Category:

© 2022 American College of Chest Physicians, All Rights Reserved. Powered By TriStar Event Media, LLC.